---
title: "Cellyan Biotechnology (HKPD.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/HKPD.US/norm.md"
symbol: "HKPD.US"
name: "Cellyan Biotechnology"
parent: "https://longbridge.com/zh-CN/quote/HKPD.US.md"
datetime: "2026-03-04T23:40:19.160Z"
locales:
  - [en](https://longbridge.com/en/quote/HKPD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HKPD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HKPD.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/HKPD.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/HKPD.US/norm.md)


# Cellyan Biotechnology (HKPD.US) — 财务报表

## 利润表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.0413 | -0.0413 | 0.0414 | 0.0414 | 0.0540 |
| ROE | -34.29% | -33.09% | 30.96% | - | 50.81% |
| 营业收入 | 4.61M | 4.61M | 5.55M | 5.55M | 4.84M |
| 净利润 | -427808.00 | -427808.00 | 414280.00 | 414280.00 | 540340.00 |
| 营业利润 | -417519.00 | -417519.00 | 512644.00 | 512644.00 | 664694.00 |
| 毛利率 | 5.53% | 5.53% | 17.18% | 17.18% | 22.96% |
| 净利率 | -9.28% | -9.28% | 7.47% | 7.47% | 11.16% |
| 利润含金量 | - | - | 136.14% | 136.14% | -428.27% |

## 资产负债表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 9.42M | 9.42M | 10.16M | 10.16M | 8.67M |
| 权益乘数 | 1.89 | 1.89 | 1.90 | 1.90 | 2.04 |
| 每股净资产 | 0.4536 | 0.4536 | 0.5352 | 0.5352 | 0.4254 |
| 资产周转率 | 2.25 | - | - | - | 2.76 |
| 现金及短投 | 3.01M | 3.01M | 364990.00 | 364990.00 | 619575.00 |
| 存货与应收 | 559982.00 | 559982.00 | 555522.00 | 555522.00 | 933299.00 |
| 长期投资 | 593734.00 | 593734.00 | 1.19M | 1.19M | 833693.00 |
| 净债务 | -630681.00 | -630681.00 | 1.98M | 1.98M | 1.47M |

## 现金流量表 (USD)

| 指标 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -91953.00 | -91953.00 | 376560.00 | 376560.00 | -155206.00 |
| 投资现金流 | -1.17M | -1.17M | -53172.00 | -53172.00 | 104929.00 |
| 融资现金流 | 1.45M | 1.45M | -456012.00 | -456012.00 | 237887.00 |
| 自由现金流 | 30446.00 | 2.41M | 488200.00 | - | 650332.00 |
| 现金流充裕率 | -10.11% | -10.11% | 98.25% | 98.25% | -27.43% |
| 举债与偿债 | 790823.00 | 790823.00 | 3726.00 | 3726.00 | 713777.00 |
| 资本支出 | -14440.00 | -14440.00 | -20518.00 | -20518.00 | -503.00 |